Societal Implications of Medical Insurance Coverage for Imatinib as First-Line Treatment of Chronic Myeloid Leukaemia in China- A Cost Effectiveness Analysis
Nov 1, 2016, 00:00
10.1016/j.jval.2016.08.309
https://www.valueinhealthjournal.com/article/S1098-3015(16)30889-0/fulltext
Title :
Societal Implications of Medical Insurance Coverage for Imatinib as First-Line Treatment of Chronic Myeloid Leukaemia in China- A Cost Effectiveness Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)30889-0&doi=10.1016/j.jval.2016.08.309
First page :
A882
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
2697